Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Infect Dis ; 21(1): 502, 2021 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-34051752

RESUMEN

BACKGROUND: Heterozygous mutations in the transcription factor GATA2 result in a wide spectrum of clinical phenotypes, including monocytopenia and Mycobacterium avium complex (MAC) infection (MonoMAC) syndrome. Patients with MonoMAC syndrome typically are infected by disseminated nontuberculous mycobacteria, fungi, and human papillomavirus, exhibit pulmonary alveolar proteinosis during late adolescence or early adulthood, and manifest with decreased content of dendritic cells (DCs), monocytes, and B and natural killer (NK) cells. CASE PRESENTATION: A 39-year-old woman was diagnosed with MonoMAC syndrome postmortem. Although she was followed up based on the symptoms associated with leukocytopenia that was disguised as sarcoidosis with bone marrow involvement, she developed disseminated nontuberculous mycobacterial infection, fungemia, and MonoMAC syndrome after childbirth. Genetic testing revealed a heterozygous missense mutation in GATA2 (c.1114G > A, p.A372T). Immunohistochemistry and flow cytometry showed the disappearance of DCs and decreased frequency of NK cells in the bone marrow, respectively, after childbirth. CONCLUSIONS: To the best of our knowledge, this is the first study reporting that MonoMAC syndrome can be exacerbated after childbirth, and that immunohistochemistry of bone marrow sections to detect decreased DC content is useful to suspect MonoMAC syndrome.


Asunto(s)
Fungemia/diagnóstico , Deficiencia GATA2/genética , Factor de Transcripción GATA2/genética , Leucopenia/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Adulto , Antibacterianos/uso terapéutico , Resultado Fatal , Femenino , Fungemia/complicaciones , Fungemia/tratamiento farmacológico , Deficiencia GATA2/complicaciones , Predisposición Genética a la Enfermedad , Humanos , Leucopenia/complicaciones , Leucopenia/tratamiento farmacológico , Ganglios Linfáticos/patología , Mutación , Infecciones por Mycobacterium no Tuberculosas/complicaciones , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Periodo Posparto , Prednisona/uso terapéutico , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA